These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33819508)

  • 1. Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy.
    Shamji MH; Larson D; Eifan A; Scadding GW; Qin T; Lawson K; Sever ML; Macfarlane E; Layhadi JA; Würtzen PA; Parkin RV; Sanda S; Harris KM; Nepom GT; Togias A; Durham SR
    J Allergy Clin Immunol; 2021 Oct; 148(4):1061-1071.e11. PubMed ID: 33819508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal allergen-neutralizing IgG
    Shamji MH; Kappen J; Abubakar-Waziri H; Zhang J; Steveling E; Watchman S; Kouser L; Eifan A; Switzer A; Varricchi G; Marone G; Couto-Francisco NC; Calderon M; Durham SR
    J Allergy Clin Immunol; 2019 Mar; 143(3):1067-1076. PubMed ID: 30445057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells.
    Scadding GW; Shamji MH; Jacobson MR; Lee DI; Wilson D; Lima MT; Pitkin L; Pilette C; Nouri-Aria K; Durham SR
    Clin Exp Allergy; 2010 Apr; 40(4):598-606. PubMed ID: 20184605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
    Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
    J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal allergen-neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with local allergic rhinitis.
    Eguiluz-Gracia I; Parkin RV; Layhadi JA; Palmer E; Meng X; Zhu R; Sahiner U; Durham SR; Torres MJ; Mayorga C; Rondon C; Shamji MH
    Allergy; 2024 Aug; 79(8):2197-2206. PubMed ID: 38483174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity.
    Nouri-Aria KT; Wachholz PA; Francis JN; Jacobson MR; Walker SM; Wilcock LK; Staple SQ; Aalberse RC; Till SJ; Durham SR
    J Immunol; 2004 Mar; 172(5):3252-9. PubMed ID: 14978133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy.
    Rondón C; Blanca-López N; Campo P; Mayorga C; Jurado-Escobar R; Torres MJ; Canto G; Blanca M
    Allergy; 2018 Apr; 73(4):905-915. PubMed ID: 29168570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy.
    Aasbjerg K; Backer V; Lund G; Holm J; Nielsen NC; Holse M; Wagtmann VR; Würtzen PA
    Clin Exp Allergy; 2014 Mar; 44(3):417-28. PubMed ID: 24734285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-beta expression.
    Pilette C; Nouri-Aria KT; Jacobson MR; Wilcock LK; Detry B; Walker SM; Francis JN; Durham SR
    J Immunol; 2007 Apr; 178(7):4658-66. PubMed ID: 17372025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
    Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
    Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgE profiles of Bermuda grass pollen sensitised patients evaluated by Phleum pratense allergens Phl P 1, 2, 4, 5, 6 , 7, 11, 12.
    Rossi RE; Monasterolo G; Prina P; Coco G; Operti D; Rossi L
    Allergol Int; 2008 Jun; 57(2):157-64. PubMed ID: 18349590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma.
    Hesse L; Brouwer U; Petersen AH; Gras R; Bosman L; Brimnes J; Oude Elberink JNG; van Oosterhout AJM; Nawijn MC
    Clin Exp Allergy; 2018 Aug; 48(8):1035-1049. PubMed ID: 29752757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy.
    Sharif H; Acharya S; Dhondalay GKR; Varricchi G; Krasner-Macleod S; Laisuan W; Switzer A; Lenormand M; Kashe E; Parkin RV; Yi Y; Koc M; Fedina O; Vilà-Nadal G; Marone G; Eifan A; Scadding GW; Fear DJ; Nadeau KC; Durham SR; Shamji MH
    J Allergy Clin Immunol; 2021 Feb; 147(2):663-676. PubMed ID: 33160969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IgE Blocking Activity Induced by Dermatophagoides pteronyssinus Subcutaneous Immunotherapy Does Not Correlate with Specific IgA but with IgG4 in both Serum and Saliva.
    He Y; Liu J; Zhao D; Zhang S; Hao G; Sun Y; Zhong H; Chen H; Würtzen PA; Larsen JN; Lai X
    Int Arch Allergy Immunol; 2021; 182(12):1231-1244. PubMed ID: 34280916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timothy specific IgE levels are associated with efficacy and safety of timothy grass sublingual immunotherapy tablet.
    Nolte M; Barber D; Maloney J; Li Z; Kaur A; Galan A; Andersen JS; Nolte H
    Ann Allergy Asthma Immunol; 2015 Dec; 115(6):509-515.e2. PubMed ID: 26507709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy.
    Altman MC; Segnitz RM; Larson D; Jayavelu ND; Smith MT; Patel S; Scadding GW; Qin T; Sanda S; Steveling E; Eifan AO; Penagos M; Jacobson MR; Parkin RV; Shamji MH; Togias A; Durham SR
    J Allergy Clin Immunol; 2023 Nov; 152(5):1247-1260. PubMed ID: 37460024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradermal grass pollen immunotherapy increases T
    Slovick A; Douiri A; Muir R; Guerra A; Tsioulos K; Hay E; Lam EPS; Kelly J; Peacock JL; Ying S; Shamji MH; Cousins DJ; Durham SR; Till SJ
    J Allergy Clin Immunol; 2017 Jun; 139(6):1830-1839.e13. PubMed ID: 27773851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.